FindTrial
Sign In

To study the colur, thickness, taste, smell of a syrup in children.

A single-centre, non-randomized, single blinded, active controlled study to evaluate and compare Organoleptic properties (Colour, Thickness, Taste, Smell and After taste) of antibiotic (co-amoxyclav) suspensions, in healthy school-going children after single use.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/052120
Enrollment
55
Registered
2023-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Advent 457 mg: The parents/guardians of participant will guide them to consume 0.5 ml – 1 ml of Test product and then help record their perception regarding colour, taste and after feel

Sponsors

Cipla Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy School going children. 2. Age criteria – 6- 9 years. 3. Parents/ legal guardian ready to sign the informed consent document.

Exclusion criteria

Exclusion criteria: 1. Having health issues and on medication. 2. Known Hypersensitivity to any of the antibiotics being studied. 3. Currently being treated with any other antibiotics. 4. Clinical suspicion of infection. 5. Presence of medical condition that would contraindicate the administration of antibiotics being studied. 6. Having known allergies to the test products. 7. Impaired stimulation/perception towards taste. 8. Lack of communication

Design outcomes

Primary

MeasureTime frame
To evaluate and compare Organoleptic properties (Colour, Thickness, Taste, Smell & After taste) of antibiotic (co-amoxyclav) suspensions, in healthy school-going children after single use, versus comparator products.Timepoint: 10 seconds—

Secondary

MeasureTime frame
NoneTimepoint: None—

Countries

India

Contacts

Public ContactAmit Mohapatra

Cipla Ltd.

sajitha.m@cipla.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026